Coexpression of TIGIT and PD-1 on CD8+ TILs, which is associated with dysfunctional antitumor immune responses, has also been observed in cancers such as HCC, glioblastoma (GBM), acute myeloid leukemia, NSCLC, and melanoma (114). This evidence concerns the gene CD8A and glioblastoma.